Low molecular weight heparin improves proteinuria in rats with L-NAME induced preeclampsia by decreasing the expression of nephrin, but not podocin

References

• Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007;196:321–7
   Google Scholar
• Zhao S, Gu X, Groome LJ, Wang Y. Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia. Reprod Sci 2009;16:970–9
   PubMed Web of Science ®Google Scholar
• Zhao S, Gu Y, Coates G, et al. Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia. Reprod Sci 2011;18:772–80
   PubMed Web of Science ®Google Scholar
• Kestilä M, Lenkkeri U, Männikkö M, et al. Positionally cloned gene for a novel glomerular protein nephrin is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575–82
   PubMed Web of Science ®Google Scholar
• Patrakka J, Tryggvason K. Nephrin – a unique structural and signaling protein of the kidney filter. Trends Mol Med 2007;13:396–403
   PubMed Web of Science ®Google Scholar
• Lahdenperä J, Kilpeläinen P, Liu XL, et al. Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. Kidney Int 2003;64:404–13
   PubMedGoogle Scholar
• Huber TB, Kottgen M, Schilling B, et al. Interaction with podocin facilitates nephrin signaling. J Biol Chem 2001;276:41543–6
   PubMed Web of Science ®Google Scholar
• Putaala H, Soininen R, Kilpelainen P, et al. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001;10:1–8
   PubMed Web of Science ®Google Scholar
• Garovic VD, Wagner SJ, Petrovic LM, et al. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 2007;22:1136–43
   PubMed Web of Science ®Google Scholar
• Vikse B, Hallan S, Bostad L, et al. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol Dial Transplant 2010;25:3289–96
   Google Scholar
• Dos Santos AM, de Olveira AV, da Silva Lemos CC, et al. Low molecular weight heparin in the treatment of puromycin-induced nephrosis. Pathol Res Pract 2006;202:157–63
   Google Scholar
• Benck U, Haeckel S, John HC, et al. Proteinuria-lowering effect of heparin therapy in diabetic nephrology without affecting the renin-angiotensin-aldosterone system. Clin J Am Soc Nephrol 2007;2:58–67
   PubMedGoogle Scholar
• Shahbazian N, Shahbazian H, Ehsanpour A, et al. Hypertension and microalbuminuria 5 years after pregnancies complicated by pre-eclampsia. Iran J Kidney Dis 2011;5:324–7
   PubMed Web of Science ®Google Scholar
• I-Kuan W, Chih-Hsin M, Yi-Chih C, et al. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ 2013;185:207–13
   Google Scholar
• Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accolmts for the biological activity of endothelium – derived relaxing factor. Nature 1987;3:524–6
   Google Scholar
• Cotechini T, Komisarenko M, Sperou A, et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med 2014;211:165–79
   PubMed Web of Science ®Google Scholar
• Yan T, Cui K, Huang X, et al. Assessment of therapeutic efficacy of miR-126 with contrast-enhanced ultrasound in preeclampsia rats. Placenta 2014;35:23–9
   PubMed Web of Science ®Google Scholar
• Fan X, Li Q, Pisarek-Horowitz A, et al. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep 2012;2:52–61
   Google Scholar
• Lenkkeri U, Männikkö M, McCready P, et al. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999;64:51–61
   PubMed Web of Science ®Google Scholar
• Feng D, Nagy JA, Brekken RA, et al. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyper-permeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000;48:545–56
   PubMedGoogle Scholar
• Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelium-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008;294:1185–94
   PubMed Web of Science ®Google Scholar
• Stratakis S, Stylianou K, Petrakis I, et al. Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy. Clin Dev Immunol 2013; DOI:10.1155/2013/941893
   Google Scholar
• Benchetrit S, Golan E, Podjarny E, et al. Low molecular weight heparin reduces proteinuria and modulates glomerular TNF-α production in the early phase of adriamycin nephropathy. Nephron 2001;87:155–60
   PubMed Web of Science ®Google Scholar
• Krzossok S, Birck R, Koeppel H, et al. Treatment of proteinuria with low-molecular-weight heparin after renal transplantation. Transplant Int 2004;17:468–72
   PubMedGoogle Scholar